This report contains market size and forecasts of Ion Channel Modulators in Global, including the following market information:
Global Ion Channel Modulators Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ion Channel Modulators market was valued at 11840 million in 2021 and is projected to reach US$ 14330 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Channel Blockers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ion Channel Modulators include Pfizer, Inc.(US), Neusentis, Inc.(US), AstraZeneca(UK), Aurora Biomed, Inc.(Canada), CalciMedica, Inc.(US), Cellectricon AB(Sweden), Convergence Pharmaceuticals Limited(UK), Cytocentrics AG(Germany) and Evotec AG(Germany), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ion Channel Modulators companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ion Channel Modulators Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ion Channel Modulators Market Segment Percentages, by Type, 2021 (%)
Channel Blockers
Channel Openers
Global Ion Channel Modulators Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ion Channel Modulators Market Segment Percentages, by Application, 2021 (%)
Clinical Trials
Hospital
Other
Global Ion Channel Modulators Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ion Channel Modulators Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ion Channel Modulators revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ion Channel Modulators revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.(US)
Neusentis, Inc.(US)
AstraZeneca(UK)
Aurora Biomed, Inc.(Canada)
CalciMedica, Inc.(US)
Cellectricon AB(Sweden)
Convergence Pharmaceuticals Limited(UK)
Cytocentrics AG(Germany)
Evotec AG(Germany)
flyion GmbH(Germany)
GlaxoSmithKline Plc.(UK)
Nanion Technologies GmbH(Germany)
NeuroSearch A/S(Denmark)
Novartis AG(Switzerland)
Parion Sciences, Inc.(US)
Sanofi(France)
Targacept, Inc.(US)
Xention Limited(UK)
Zalicus, Inc.(US)